Benchmark Genetics shifts HQ to Bergen following Novo acquisition. Novo Holdings has completed its acquisition of Benchmark Genetics, the aquaculture genetics division of UK-based Benchmark Holdings, in a transaction valued at up to £260 million. The deal, finalised on 31 March 2025, includes £230 million paid on completion and a further £30 million contingent on … Continue reading Novo Holdings completes £260m acquisition of Benchmark Genetics